retatrutide phase 2 trial type 2 diabetes results 2024 Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first 3 for treatment of Phase 2 trial results demonstrate
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18


















![Free 7-Day GLP-1 Meal Plan | Ozempic & Wegovy [PDF]](https://chase-wellness.com/og-glp1-nutrition-guide.png)








